{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T04:28:20Z","timestamp":1780806500518,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,24]],"date-time":"2026-12-24T00:00:00Z","timestamp":1798070400000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS107281"],"award-info":[{"award-number":["NS107281"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS134586"],"award-info":[{"award-number":["NS134586"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS103988"],"award-info":[{"award-number":["NS103988"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS061025"],"award-info":[{"award-number":["NS061025"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS075527"],"award-info":[{"award-number":["NS075527"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R00AI159380"],"award-info":[{"award-number":["R00AI159380"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006309","name":"American Parkinson Disease Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["EB025815"],"award-info":[{"award-number":["EB025815"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH092797"],"award-info":[{"award-number":["MH092797"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bmc.2025.118536","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T07:24:08Z","timestamp":1766215448000},"page":"118536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery and in vivo evaluation of a fluorine-18 pro-drug tracer for imaging sphingosine-1-phosphate receptor 2 in the brain"],"prefix":"10.1016","volume":"134","author":[{"given":"Lin","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Heady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Gropler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Guglielmetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhude","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118536_bb0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-phosphate: an enigmatic signalling lipid","volume":"4","author":"Spiegel","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2025.118536_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1242\/dev.094805","article-title":"Sphingosine 1-phosphate signalling","volume":"141","author":"Mendelson","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.bmc.2025.118536_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2025.118536_bb0020","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/med.22044","article-title":"An overview of sphingosine-1-phosphate receptor 2: structure, biological function, and small-molecule modulators","volume":"44","author":"Hao","year":"2024","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2025.118536_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.0953-816x.2001.01634.x","article-title":"An essential role for the H218\/AGR16\/Edg-5\/LPB2 sphingosine 1-phosphate receptor in neuronal excitability","volume":"14","author":"MacLennan","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bmc.2025.118536_bb0030","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1161\/ATVBAHA.109.191965","article-title":"Sphingosine-1-phosphate RECEPTOR-2 regulates expression of smooth muscle alpha-actin after arterial injury","volume":"29","author":"Grabski","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bmc.2025.118536_bb0035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1194\/jlr.M800496-JLR200","article-title":"Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2","volume":"50","author":"Ikeda","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bmc.2025.118536_bb0040","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1096\/fj.14-263194","article-title":"Sphingosine 1-phosphate counteracts insulin signaling in pancreatic \u03b2-cells via the sphingosine 1-phosphate receptor subtype 2","volume":"29","author":"Japtok","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2025.118536_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2018.11.018","article-title":"Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis","volume":"124","author":"Seyedsadr","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bmc.2025.118536_bb0050","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1172\/JCI73408","article-title":"Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility","volume":"124","author":"Cruz-Orengo","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2025.118536_bb0055","article-title":"Positron emission tomography (PET)\/computed tomography (CT) imaging in radiation therapy treatment planning: a review of PET imaging tracers and methods to incorporate PET\/CT","volume":"8","author":"Trotter","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.bmc.2025.118536_bb0060","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/s41467-023-36377-4","article-title":"Radiochemistry for positron emission tomography","volume":"14","author":"Rong","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2025.118536_bb0065","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/postgradmedj-2014-133178","article-title":"Modern imaging techniques: applications in the management of acute aortic pathologies","volume":"91","author":"Nagpal","year":"2015","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.bmc.2025.118536_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2125.2011.04085.x","article-title":"Positron emission tomography molecular imaging for drug development","volume":"73","author":"Matthews","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bmc.2025.118536_bb0075","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/j.semnuclmed.2017.05.005","article-title":"Small molecule PET tracers for transporter imaging","volume":"47","author":"Kilbourn","year":"2017","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.bmc.2025.118536_bb0080","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1039\/C5OB00951K","article-title":"A potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression","volume":"13","author":"Yue","year":"2015","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1039\/D1MD00357G","article-title":"Synthesis and evaluation of highly selective quinazoline-2,4-dione ligands for sphingosine-1-phosphate receptor 2","volume":"13","author":"Luo","year":"2022","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0090","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/j.bmc.2019.06.047","article-title":"Design, synthesis, and in vitro bioactivity evaluation of fluorine-containing analogues for sphingosine-1-phosphate 2 receptor","volume":"27","author":"Luo","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bmcl.2017.12.010","article-title":"Design and synthesis of pyrazolopyridine derivatives as sphingosine 1-phosphate receptor 2 ligands","volume":"28","author":"Luo","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118536_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nucmedbio.2020.07.007","article-title":"Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2","volume":"88-89","author":"Luo","year":"2020","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmc.2025.118536_bb0105","doi-asserted-by":"crossref","first-page":"14557","DOI":"10.1021\/acs.jmedchem.1c01066","article-title":"Discovery and optimization of orally bioavailable phthalazone and cinnolone carboxylic acid derivatives as S1P2 antagonists against fibrotic diseases","volume":"64","author":"Mammoliti","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.nucmedbio.2025.108992","article-title":"First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparaginate, [18F]RP-115","volume":"142-143","author":"Chao","year":"2025","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmc.2025.118536_bb0115","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1021\/acs.jmedchem.5b00652","article-title":"Development of fluorine-18 labeled metabolically activated tracers for imaging of drug efflux transporters with positron emission tomography","volume":"58","author":"Sander","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0120","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1021\/jm401764a","article-title":"Development of purine-derived 18F-labeled pro-drug tracers for imaging of MRP1 activity with PET","volume":"57","author":"Galante","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0125","doi-asserted-by":"crossref","first-page":"10357","DOI":"10.1021\/acs.jmedchem.1c02226","article-title":"Rationally designed amanitins achieve enhanced cytotoxicity","volume":"65","author":"Todorovic","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0130","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1021\/ja00099a076","article-title":"Use of pseudoephedrine as a practical chiral auxiliary for asymmetric synthesis","volume":"116","author":"Myers","year":"1994","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118536_bb0135","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nature05757","article-title":"Expanding the diversity of chemical protein modification allows post-translational mimicry","volume":"446","author":"van Kasteren","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118536_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.apradiso.2015.04.010","article-title":"A practical process for the preparation of [32P]S1P and binding assay for S1P receptor ligands","volume":"102","author":"Rosenberg","year":"2015","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.bmc.2025.118536_bb0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2025.118536_bb0150","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0155","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/jm060642i","article-title":"Structure\u2212brain exposure relationships","volume":"49","author":"Hitchcock","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0160","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2174\/0929867323666160418114826","article-title":"Considerations in the development of reversibly binding PET radioligands for brain imaging","volume":"23","author":"Pike","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuroimage.2013.07.080","article-title":"Multimodal imaging of subventricular zone neural stem\/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum","volume":"86","author":"Guglielmetti","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.bmc.2025.118536_bb0170","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bmc.2025.118536_bb0175","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/nbm.3277","article-title":"Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra","volume":"28","author":"Praet","year":"2015","journal-title":"NMR Biomed"},{"key":"10.1016\/j.bmc.2025.118536_bb0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12974-016-0756-7","article-title":"Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model","volume":"13","author":"Le Blon","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bmc.2025.118536_bb0185","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.7150\/thno.32461","article-title":"Molecular imaging of immune cell dynamics during de- and remyelination in the cuprizone model of multiple sclerosis by [18F]DPA-714 PET and MRI","volume":"9","author":"Zinnhardt","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bmc.2025.118536_bb0190","doi-asserted-by":"crossref","first-page":"E6982","DOI":"10.1073\/pnas.1613345114","article-title":"Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model","volume":"114","author":"Guglielmetti","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2025.118536_bb0195","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bioorg.2018.09.018","article-title":"Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen","volume":"81","author":"Huttunen","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9982020","article-title":"PET study of Sphingosine-1-phosphate receptor 1 expression in response to S. aureus infection","volume":"2021","author":"Jiang","year":"2021","journal-title":"Mol Imaging"},{"key":"10.1016\/j.bmc.2025.118536_bb0205","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1039\/D1OB02225C","article-title":"Radiosynthesis and evaluation of a fluorine-18 radiotracer [18F]FS1P1 for imaging sphingosine-1-phosphate receptor 1","volume":"20","author":"Qiu","year":"2022","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2025.118536_bb0210","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1021\/acschemneuro.1c00492","article-title":"In vitro and in vivo investigation of S1PR1 expression in the central nervous system using [3H]CS1P1 and [11C]CS1P1","volume":"12","author":"Jiang","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2025.118536_bb0215","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1021\/jm400664x","article-title":"Heteroaromatic and aniline derivatives of piperidines as potent ligands for vesicular acetylcholine transporter","volume":"56","author":"Li","year":"2013","journal-title":"J Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962500478X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962500478X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:44:28Z","timestamp":1773953068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962500478X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":43,"alternative-id":["S096808962500478X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118536","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and in vivo evaluation of a fluorine-18 pro-drug tracer for imaging sphingosine-1-phosphate receptor 2 in the brain","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118536"}}